Advertisement

Activation of the Hemagglutinin of Influenza Viruses

  • Summer E. Galloway
  • Bo Liang
  • David A. Steinhauer
Chapter

Abstract

The hemagglutinin (HA) glycoprotein of influenza viruses is posttranslationally cleaved into the disulfide-linked subunits HA1 and HA2, and this proteolytic processing event is critical to the virus life cycle as it is required to activate membrane fusion potential and virus infectivity. High-resolution structures are available for the HA precursor (HA0), the cleaved neutral pH conformation of HA, and the low pH conformation that the HA assumes when triggered by acidification of endosomes to mediate fusion of viral and cellular membrane during virus entry. These structures have provided clues regarding the mechanisms by which proteolytic cleavage activates membrane fusion potential and how subsequent acidification drives the fusion process. It has been known for decades that influenza strains and subtypes can vary with regard to HA cleavage properties and that cleavage site sequences and the proteases that recognize them can represent a major determinant for virus pathogenicity. However, a number of questions remain with respect to the identity and characteristics of the proteases that activate HAs in the various natural hosts and complex ecosystems that constitute the realm of influenza viruses. The continuing study of HA cleavage properties and the proteases involved should illuminate our understanding not only of pathogenicity but other aspects of influenza biology including host range, transmission, and interplay with other microorganisms such as bacteria.

Keywords

Influenza virus Hemagglutinin Activating proteases Membrane fusion pH optimum Pathogenesis 

Notes

Acknowledgments

The authors acknowledge the support by the US Department of Health and Human Services contract HHSN272201400004C (NIAID Centers of Excellence for Influenza Research and Surveillance).

References

  1. Air GM. Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus. Proc Natl Acad Sci U S A. 1981;78:7639–43.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Appleyard G, Maber HB. Plaque formation by influenza viruses in the presence of trypsin. J Gen Virol. 1974;25:351–7.PubMedCrossRefGoogle Scholar
  3. Baron J, Tarnow C, Mayoli-Nüssle D, Schilling E, Meyer D, Hammami M, Schwalm F, Steinmetzer T, Guan Y, Garten W, Klenk HD, Böttcher-Friebertshäuser E. Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses. J Virol. 2013;87:1811–20.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Bertram S, Glowacka I, Blazejewska P, Soilleux E, Allen P, Danisch S, Steffen I, Choi SY, Park Y, Schneider H, Schughart K, Pohlmann S. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. J Virol. 2010a;84:10016–25.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Bertram S, Glowacka I, Steffen I, Kuhl A, Pohlmann S. Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev Med Virol. 2010b;20:298–310.PubMedCrossRefGoogle Scholar
  6. Bertram S, Heurich A, Lavender H, Gierer S, Danisch S, Perin P, Lucas JM, Nelson PS, Pohlmann S, Soilleux EJ. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One. 2012;7:e35876.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, Bosecke P, Wharton SA, Skehel JJ, Knossow M. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature. 1995;376:92–4.PubMedCrossRefGoogle Scholar
  8. Bosch FX, Garten W, Klenk HD, Rott R. Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of Avian influenza viruses. Virology. 1981;113:725–35.PubMedCrossRefGoogle Scholar
  9. Bottcher E, Freuer C, Steinmetzer T, Klenk HD, Garten W. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine. 2009;27:6324–9.PubMedCrossRefGoogle Scholar
  10. Bottcher E, Matrosovich T, Beyerle M, Klenk HD, Garten W, Matrosovich M. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol. 2006;80:9896–8.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Bottcher-Friebertshauser E, Garten W, Matrosovich M, Klenk HD. The hemagglutinin: a determinant of pathogenicity. Curr Top Microbiol Immunol. 2014;385:3–34.PubMedGoogle Scholar
  12. Boycott R, Klenk HD, Ohuchi M. Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. Virology. 1994;203:313–9.PubMedCrossRefGoogle Scholar
  13. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 1994;371:37–43.PubMedCrossRefGoogle Scholar
  14. Byrd-Leotis L, Galloway SE, Agbogu E, Steinhauer DA. Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes. J Virol. 2015;89:4504–16.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Calder LJ, Rosenthal PB. Cryomicroscopy provides structural snapshots of influenza virus membrane fusion. Nat Struct Mol Biol. 2016;23:853–8.PubMedCrossRefGoogle Scholar
  16. Came PE, Pascale A, Shimonaski G. Effect of pancreatin on plaque formation by influenza viruses. Arch Gesamte Virusforsch. 1968;23:346–52.PubMedCrossRefGoogle Scholar
  17. Carr CM, Chaudhry C, Kim PS. Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci U S A. 1997;94:14306–13.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Chaipan C, Kobasa D, Bertram S, Glowacka I, Steffen I, Tsegaye TS, Takeda M, Bugge TH, Kim S, Park Y, Marzi A, Pohlmann S. Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol. 2009;83:3200–11.PubMedPubMedCentralCrossRefGoogle Scholar
  19. Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell. 1998;95:409–17.PubMedCrossRefGoogle Scholar
  20. Chen J, Skehel JJ, Wiley DC. N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A. 1999;96:8967–72.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Chen J, Wharton SA, Weissenhorn W, Calder LJ, Hughson FM, Skehel JJ, Wiley DC. A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc Natl Acad Sci U S A. 1995;92:12205–9.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Cross KJ, Langley WA, Russell RJ, Skehel JJ, Steinhauer DA. Composition and functions of the influenza fusion peptide. Protein Pept Lett. 2009;16:766–78.PubMedCrossRefGoogle Scholar
  23. Cross KJ, Wharton SA, Skehel JJ, Wiley DC, Steinhauer DA. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics. EMBO J. 2001;20:4432–42.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, Wiley DC. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell. 1985;40:431–9.PubMedCrossRefGoogle Scholar
  25. Deshpande KL, Fried VA, Ando M, Webster RG. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc Natl Acad Sci U S A. 1987;84:36–40.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Dittmann M, Hoffmann HH, Scull MA, Gilmore RH, Bell KL, Ciancanelli M, Wilson SJ, Crotta S, Yu Y, Flatley B, Xiao JW, Casanova JL, Wack A, Bieniasz PD, Rice CM. A serpin shapes the extracellular environment to prevent influenza A virus maturation. Cell. 2015;160:631–43.PubMedPubMedCentralCrossRefGoogle Scholar
  27. Doms RW, Gething MJ, Henneberry J, White J, Helenius A. Variant influenza virus hemagglutinin that induces fusion at elevated pH. J Virol. 1986;57:603–13.PubMedPubMedCentralGoogle Scholar
  28. Francis T, Moore AE. A Study of the Neurotropic Tendency in Strains of the Virus of Epidemic Influenza. J Exp Med. 1940;72:717–28.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Galloway SE, Reed ML, Russell CJ, Steinhauer DA. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog. 2013;9:e1003151.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Garcia NK, Guttman M, Ebner JL, Lee KK. Dynamic changes during acid-induced activation of influenza hemagglutinin. Structure. 2015;23:665–76.PubMedPubMedCentralCrossRefGoogle Scholar
  31. Garten W, Bosch FX, Linder D, Rott R, Klenk HD. Proteolytic activation of the influenza virus hemagglutinin: the structure of the cleavage site and the enzymes involved in cleavage. Virology. 1981;115:361–74.PubMedCrossRefGoogle Scholar
  32. Garten W, Klenk HD. Understanding influenza virus pathogenicity. Trends Microbiol. 1999;7:99–100.PubMedCrossRefGoogle Scholar
  33. Gething MJ, Doms RW, York D, White J. Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J Cell Biol. 1986;102:11–23.PubMedCrossRefGoogle Scholar
  34. Goto H, Kawaoka Y. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci U S A. 1998;95:10224–8.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Gotoh B, Ogasawara T, Toyoda T, Inocencio NM, Hamaguchi M, Nagai Y. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J. 1990;9:4189–95.PubMedPubMedCentralCrossRefGoogle Scholar
  36. Hamilton BS, Gludish DW, Whittaker GR. Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities. J Virol. 2012;86:10579–86.PubMedPubMedCentralCrossRefGoogle Scholar
  37. Hamilton BS, Whittaker GR. Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12. J Biol Chem. 2013;288:17399–407.PubMedPubMedCentralCrossRefGoogle Scholar
  38. Hatesuer B, Bertram S, Mehnert N, Bahgat MM, Nelson PS, Pohlmann S, Schughart K. Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice. PLoS Pathog. 2013;9:e1003774.PubMedPubMedCentralCrossRefGoogle Scholar
  39. Horimoto T, Nakayama K, Smeekens SP, Kawaoka Y. Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J Virol. 1994;68:6074–8.PubMedPubMedCentralGoogle Scholar
  40. Huang RT, Wahn K, Klenk HD, Rott R. Fusion between cell membrane and liposomes containing the glycoproteins of influenza virus. Virology. 1980;104:294–302.PubMedCrossRefGoogle Scholar
  41. Huang RT, Rott R, Klenk HD. Influenza viruses cause hemolysis and fusion of cells. Virology. 1981;110:243–7.PubMedCrossRefGoogle Scholar
  42. Ivanovic T, Choi JL, Whelan SP, van Oijen AM, Harrison SC. Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates. elife. 2013;2:e00333.PubMedPubMedCentralCrossRefGoogle Scholar
  43. Kawaoka Y, Naeve CW, Webster RG. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology. 1984;139:303–16.PubMedCrossRefGoogle Scholar
  44. Kawaoka Y, Webster RG. Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin. J Virol. 1989;63:3296–300.PubMedPubMedCentralGoogle Scholar
  45. Keawcharoen J, Spronken MI, Vuong O, Bestebroer TM, Munster VJ, Osterhaus AD, Rimmelzwaan GF, Fouchier RA. Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant viruses. Vaccine. 2010;28:5803–9.PubMedPubMedCentralCrossRefGoogle Scholar
  46. Khatchikian D, Orlich M, Rott R. Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus. Nature. 1989;340:156–7.PubMedCrossRefGoogle Scholar
  47. Kido H, Yokogoshi Y, Sakai K, Tashiro M, Kishino Y, Fukutomi A, Katunuma N. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem. 1992;267:13573–9.PubMedPubMedCentralGoogle Scholar
  48. Kim TS, Heinlein C, Hackman RC, Nelson PS. Phenotypic analysis of mice lacking the Tmprss2-encoded protease. Mol Cell Biol. 2006;26:965–75.PubMedPubMedCentralCrossRefGoogle Scholar
  49. Klenk HD, Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 1994;2:39–43.CrossRefPubMedGoogle Scholar
  50. Klenk HD, Garten W, Rott R. Inhibition of proteolytic cleavage of the hemagglutinin of influenza virus by the calcium-specific ionophore A23187. EMBO J. 1984;3:2911–5.PubMedPubMedCentralCrossRefGoogle Scholar
  51. Klenk HD, Rott R, Orlich M, Blodorn J. Activation of influenza A viruses by trypsin treatment. Virology. 1975;68:426–39.PubMedCrossRefGoogle Scholar
  52. Korte T, Epand RF, Epand RM, Blumenthal R. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity. Virology. 2001;289:353–61.PubMedCrossRefGoogle Scholar
  53. Kuhn N, Bergmann S, Kosterke N, Lambertz RL, Keppner A, van den Brand JM, Pohlmann S, Weiss S, Hummler E, Hatesuer B, Schughart K. The proteolytic activation of (H3N2) influenza A virus hemagglutinin is facilitated by different type II transmembrane serine proteases. J Virol. 2016;90:4298–307.PubMedPubMedCentralCrossRefGoogle Scholar
  54. Langley WA, Thoennes S, Bradley KC, Galloway SE, Talekar GR, Cummings SF, Vareckova E, Russell RJ, Steinhauer DA. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function. Virology. 2009;394:321–30.PubMedCrossRefGoogle Scholar
  55. Lazarowitz SG, Choppin PW. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology. 1975;68:440–54.PubMedCrossRefGoogle Scholar
  56. Lazarowitz SG, Compans RW, Choppin PW. Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA. Virology. 1973a;52:199–212.PubMedCrossRefGoogle Scholar
  57. Lazarowitz SG, Goldberg AR, Choppin PW. Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. Virology. 1973b;56:172–80.PubMedCrossRefGoogle Scholar
  58. Li S, Schulman J, Itamura S, Palese P. Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J Virol. 1993;67:6667–73.PubMedPubMedCentralGoogle Scholar
  59. Lin YP, Wharton SA, Martin J, Skehel JJ, Wiley DC, Steinhauer DA. Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. Virology. 1997;233:402–10.PubMedCrossRefGoogle Scholar
  60. Lu X, Shi Y, Gao F, Xiao H, Wang M, Qi J, Gao GF. Insights into avian influenza virus pathogenicity: the hemagglutinin precursor HA0 of subtype H16 has an alpha-helix structure in its cleavage site with inefficient HA1/HA2 cleavage. J Virol. 2012;86:12861–70.PubMedPubMedCentralCrossRefGoogle Scholar
  61. Maeda H. Role of microbial proteases in pathogenesis. Microbiol Immunol. 1996;40:685–99.PubMedCrossRefGoogle Scholar
  62. Maeda T, Ohnishi S. Activation of influenza virus by acidic media causes hemolysis and fusion of erythrocytes. FEBS Lett. 1980;122:283–7.PubMedCrossRefGoogle Scholar
  63. Maurer-Stroh S, Lee RT, Gunalan V, Eisenhaber F. The highly pathogenic H7N3 avian influenza strain from July 2012 in Mexico acquired an extended cleavage site through recombination with host 28S rRNA. Virol J. 2013;10:139.PubMedPubMedCentralCrossRefGoogle Scholar
  64. Munster VJ, Baas C, Lexmond P, Waldenstrom J, Wallensten A, Fransson T, Rimmelzwaan GF, Beyer WE, Schutten M, Olsen B, Osterhaus AD, Fouchier RA. Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog. 2007;3:e61.PubMedPubMedCentralCrossRefGoogle Scholar
  65. Nobusawa E, Aoyama T, Kato H, Suzuki Y, Tateno Y, Nakajima K. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology. 1991;182:475–85.PubMedCrossRefGoogle Scholar
  66. Nobusawa E, Hishida R, Murata M, Kawasaki K, Ohnishi S, Nakajima K. The role of acidic residues in the “fusion segment” of influenza A virus hemagglutinin in low-pH-dependent membrane fusion. Arch Virol. 1995;140:865–75.PubMedCrossRefGoogle Scholar
  67. Ohuchi R, Ohuchi M, Garten W, Klenk HD. Human influenza virus hemagglutinin with high sensitivity to proteolytic activation. J Virol. 1991;65:3530–7.PubMedPubMedCentralGoogle Scholar
  68. Okumura Y, Takahashi E, Yano M, Ohuchi M, Daidoji T, Nakaya T, Bottcher E, Garten W, Klenk HD, Kido H. Novel type II transmembrane serine proteases, MSPL and TMPRSS13, proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication. J Virol. 2010;84:5089–96.PubMedPubMedCentralCrossRefGoogle Scholar
  69. Orlich M, Gottwald H, Rott R. Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus. Virology. 1994;204:462–5.PubMedCrossRefGoogle Scholar
  70. Orlich M, Rott R. Thermolysin activation mutants with changes in the fusogenic region of an influenza virus hemagglutinin. J Virol. 1994;68:7537–9.PubMedPubMedCentralGoogle Scholar
  71. Pasick J, Handel K, Robinson J, Copps J, Ridd D, Hills K, Kehler H, Cottam-Birt C, Neufeld J, Berhane Y, Czub S. Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia. J Gen Virol. 2005;86:727–31.PubMedCrossRefGoogle Scholar
  72. Perdue ML, Garcia M, Senne D, Fraire M. Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses. Virus Res. 1997;49:173–86.PubMedCrossRefGoogle Scholar
  73. Qiao H, Armstrong RT, Melikyan GB, Cohen FS, White JM. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol Biol Cell. 1999;10:2759–69.PubMedPubMedCentralCrossRefGoogle Scholar
  74. Ruigrok RW, Aitken A, Calder LJ, Martin SR, Skehel JJ, Wharton SA, Weis W, Wiley DC. Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J Gen Virol. 1988;69(Pt 11):2785–95.PubMedCrossRefGoogle Scholar
  75. Russell RJ, Gamblin SJ, Haire LF, Stevens DJ, Xiao B, Ha Y, Skehel JJ. H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology. 2004;325:287–96.PubMedCrossRefGoogle Scholar
  76. Sakai K, Ami Y, Nakajima N, Nakajima K, Kitazawa M, Anraku M, Takayama I, Sangsriratanakul N, Komura M, Sato Y, Asanuma H, Takashita E, Komase K, Takehara K, Tashiro M, Hasegawa H, Odagiri T, Takeda M. TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus. Sci Rep. 2016;6:29430.PubMedPubMedCentralCrossRefGoogle Scholar
  77. Sakai K, Ami Y, Tahara M, Kubota T, Anraku M, Abe M, Nakajima N, Sekizuka T, Shirato K, Suzaki Y, Ainai A, Nakatsu Y, Kanou K, Nakamura K, Suzuki T, Komase K, Nobusawa E, Maenaka K, Kuroda M, Hasegawa H, Kawaoka Y, Tashiro M, Takeda M. The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol. 2014;88:5608–16.PubMedPubMedCentralCrossRefGoogle Scholar
  78. Sales KU, Hobson JP, Wagenaar-Miller R, Szabo R, Rasmussen AL, Bey A, Shah MF, Molinolo AA, Bugge TH. Expression and genetic loss of function analysis of the HAT/DESC cluster proteases TMPRSS11A and HAT. PLoS One. 2011;6:e23261.PubMedPubMedCentralCrossRefGoogle Scholar
  79. Scheiblauer H, Reinacher M, Tashiro M, Rott R. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J Infect Dis. 1992;166:783–91.PubMedCrossRefGoogle Scholar
  80. Shope RE. The etiology of swine influenza. Science. 1931;73:214–5.PubMedCrossRefGoogle Scholar
  81. Skehel JJ, Waterfield MD. Studies on the primary structure of the influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1975;72:93–7.PubMedPubMedCentralCrossRefGoogle Scholar
  82. Slusher MJ, Wilcox BR, Lutrell MP, Poulson RL, Brown JD, Yabsley MJ, Stallknecht DE. Are passerine birds reservoirs for influenza A viruses? J Wildl Dis. 2014;50:792–809.PubMedCrossRefGoogle Scholar
  83. Smith W, Andrewes CH, Laidlaw PP. A virus obtained from influenza patients. Lancet. 1933;2:66–8.CrossRefGoogle Scholar
  84. Steinhauer DA. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology. 1999;258:1–20.PubMedCrossRefGoogle Scholar
  85. Steinhauer DA, Martin J, Lin YP, Wharton SA, Oldstone MB, Skehel JJ, Wiley DC. Studies using double mutants of the conformational transitions in influenza hemagglutinin required for its membrane fusion activity. Proc Natl Acad Sci U S A. 1996;93:12873–8.PubMedPubMedCentralCrossRefGoogle Scholar
  86. Steinhauer DA, Wharton SA, Skehel JJ, Wiley DC. Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin. J Virol. 1995;69:6643–51.PubMedPubMedCentralGoogle Scholar
  87. Steinhauer DA, Wharton SA, Skehel JJ, Wiley DC, Hay AJ. Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci U S A. 1991;88:11525–9.PubMedPubMedCentralCrossRefGoogle Scholar
  88. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, Wilson IA. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science. 2004;303:1866–70.PubMedCrossRefGoogle Scholar
  89. Stieneke-Grober A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C, Klenk HD, Garten W. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 1992;11:2407–14.PubMedPubMedCentralCrossRefGoogle Scholar
  90. Suarez DL, Senne DA, Banks J, Brown IH, Essen SC, Lee CW, Manvell RJ, Mathieu-Benson C, Moreno V, Pedersen JC, Panigrahy B, Rojas H, Spackman E, Alexander DJ. Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis. 2004;10:693–9.PubMedPubMedCentralCrossRefGoogle Scholar
  91. Sun X, Tse LV, Ferguson AD, Whittaker GR. Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus. J Virol. 2010;84:8683–90.PubMedPubMedCentralCrossRefGoogle Scholar
  92. Tarnow C, Engels G, Arendt A, Schwalm F, Sediri H, Preuss A, Nelson PS, Garten W, Klenk HD, Gabriel G, Bottcher-Friebertshauser E. TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice. J Virol. 2014;88:4744–51.PubMedPubMedCentralCrossRefGoogle Scholar
  93. Tashiro M, Ciborowski P, Klenk HD, Pulverer G, Rott R. Role of Staphylococcus protease in the development of influenza pneumonia. Nature. 1987;325(6104):536–7.PubMedCrossRefGoogle Scholar
  94. Thoennes S, Li ZN, Lee BJ, Langley WA, Skehel JJ, Russell RJ, Steinhauer DA. Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion. Virology. 2008;370:403–14.PubMedCrossRefGoogle Scholar
  95. Tobita K, Kilbourne ED. Genetic recombination for antigenic markers of antigenically different strains of influenza B virus. J Virol. 1974;13:347–52.PubMedPubMedCentralGoogle Scholar
  96. Tse LV, Marcano VC, Huang W, Pocwierz MS, Whittaker GR. Plasmin-mediated activation of pandemic H1N1 influenza virus hemagglutinin is independent of the viral neuraminidase. J Virol. 2013;87:5161–9.PubMedPubMedCentralCrossRefGoogle Scholar
  97. Veits J, Weber S, Stech O, Breithaupt A, Graber M, Gohrbandt S, Bogs J, Hundt J, Teifke JP, Mettenleiter TC, Stech J. Avian influenza virus hemagglutinins H2, H4, H8, and H14 support a highly pathogenic phenotype. Proc Natl Acad Sci U S A. 2012;109:2579–84.PubMedPubMedCentralCrossRefGoogle Scholar
  98. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56:152–79.PubMedPubMedCentralGoogle Scholar
  99. White J, Helenius A. pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc Natl Acad Sci U S A. 1980;77:3273–7.PubMedPubMedCentralCrossRefGoogle Scholar
  100. White JM, Wilson IA. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J Cell Biol. 1987;105:2887–96.PubMedCrossRefGoogle Scholar
  101. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature. 1981;289:366–73.PubMedCrossRefGoogle Scholar
  102. World Health Organization. (2018). Influenza at the human-animal interface [PDF file]. Retrieved from http://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_25_01_2018_FINAL.pdf?ua=1
  103. Xu R, Wilson IA. Structural characterization of an early fusion intermediate of influenza virus hemagglutinin. J Virol. 2011;85:5172–82.PubMedPubMedCentralCrossRefGoogle Scholar
  104. Xu Y, Ramey AM, Bowman AS, DeLiberto TJ, Killian ML, Krauss S, Nolting JM, Torchetti MK, Reeves AB, Webby RJ, Stallknecht DE, Wan XF. Low-pathogenic influenza A viruses in North American Diving Ducks contribute to the emergence of a novel highly pathogenic influenza A(H7N8) virus. J Virol. 2017;91:pii: e02208-16.CrossRefGoogle Scholar
  105. Yewdell JW, Taylor A, Yellen A, Caton A, Gerhard W, Bachi T. Mutations in or near the fusion peptide of the influenza virus hemagglutinin affect an antigenic site in the globular region. J Virol. 1993;67:933–42.PubMedPubMedCentralGoogle Scholar
  106. Zaraket H, Bridges OA, Duan S, Baranovich T, Yoon SW, Reed ML, Salomon R, Webby RJ, Webster RG, Russell CJ. Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets. J Virol. 2013a;87:9911–22.PubMedPubMedCentralCrossRefGoogle Scholar
  107. Zaraket H, Bridges OA, Russell CJ. The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice. J Virol. 2013b;87:4826–34.PubMedPubMedCentralCrossRefGoogle Scholar
  108. Zhang F, Bi Y, Wang J, Wong G, Shi W, Hu F, Yang Y, Yang L, Deng X, Jiang S, He X, Liu Y, Yin C, Zhong N, Gao GF. Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China. J Infect. 2017;75:71–5.PubMedCrossRefGoogle Scholar
  109. Zhirnov OP, Ikizler MR, Wright PF. Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases. J Virol. 2002;76:8682–9.PubMedPubMedCentralCrossRefGoogle Scholar
  110. Zhu W, Zhou J, Li Z, Yang L, Li X, Huang W, Zou S, Chen W, Wei H, Tang J, Liu L, Dong J, Wang D, Shu Y. Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017. Euro Surveill. 2017;22(19):pii: 30533.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Summer E. Galloway
    • 1
  • Bo Liang
    • 2
  • David A. Steinhauer
    • 3
  1. 1.Influenza Division, National Center for Immunization and Respiratory DiseasesCenters for Disease Control and PreventionAtlantaUSA
  2. 2.Department of Biochemistry, O. Wayne Rollins Research CenterEmory University School of MedicineAtlantaUSA
  3. 3.Department of Microbiology and Immunology, O. Wayne Rollins Research CenterEmory University School of MedicineAtlantaUSA

Personalised recommendations